AtriCure, Inc. Completes Acquisition Of ESTECH

Published: Jan 02, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading Atrial Fibrillation medical device provider, today announced the completion of the previously announced acquisition of Endoscopic Technologies, Inc. d/b/a Estech (“Estech”). Estech develops and markets a portfolio of innovative surgical ablation devices that enable physicians to perform a variety of traditional and minimally invasive procedures using Estech’s proprietary temperature controlled RF energy.

Help employers find you! Check out all the jobs and post your resume.

Back to news